Background: Machine learning (ML) models have been constructed to predict the risk of in-hospital mortality in patients with myocardial infarction (MI). Due to diverse ML models and modeling variables, along with the significant imbalance in data, the predictive accuracy of these models remains controversial.

Objective: This study aimed to review the accuracy of ML in predicting in-hospital mortality risk in MI patients and to provide evidence-based advices for the development or updating of clinical tools.

Methods: PubMed, Embase, Cochrane, and Web of Science databases were searched, up to June 4, 2024. PROBAST and ChAMAI checklist are utilized to assess the risk of bias in the included studies. Since the included studies constructed models based on severely unbalanced datasets, subgroup analyses were conducted by the type of dataset (balanced data, unbalanced data, model type).

Results: This meta-analysis included 32 studies. In the validation set, the pooled C-index, sensitivity, and specificity of prediction models based on balanced data were 0.83 (95 % CI: 0.795-0.866), 0.81 (95 % CI: 0.79-0.84), and 0.82 (95 % CI: 0.78-0.86), respectively. In the validation set, the pooled C-index, sensitivity, and specificity of ML models based on imbalanced data were 0.815 (95 % CI: 0.789-0.842), 0.66 (95 % CI: 0.60-0.72), and 0.84 (95 % CI: 0.83-0.85), respectively.

Conclusions: ML models such as LR, SVM, and RF exhibit high sensitivity and specificity in predicting in-hospital mortality in MI patients. However, their sensitivity is not superior to well-established scoring tools. Mitigating the impact of imbalanced data on ML models remains challenging.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijmedinf.2025.105875DOI Listing

Publication Analysis

Top Keywords

in-hospital mortality
16
included studies
12
models based
12
sensitivity specificity
12
machine learning
8
mortality risk
8
myocardial infarction
8
models
8
mortality patients
8
models remains
8

Similar Publications

Background: Chronic Obstructive Pulmonary Disease (COPD) is a heterogeneous condition with different risk factors, including family history. This study aimed to explore association between a family history of chronic airway disease and features and outcomes of COPD.

Methods: Participants were obtained from the RealDTC study between December 2016 and December 2022.

View Article and Find Full Text PDF

Linking epidemiology and genomics of maternal smoking during pregnancy in utero and in ageing: a population-based study using human foetuses and the UK Biobank cohort.

EBioMedicine

February 2025

Institute of Medical Sciences, School of Medicine, Medical Sciences & Nutrition, University of Aberdeen, Aberdeen, UK; Institute for Clinical Research and Systems Medicine, Health and Medical University, Potsdam, Germany.

Background: Maternal smoking and foetal exposure to nicotine and other harmful chemicals in utero remains a serious public health issue with little knowledge about the underlying genetics and consequences of maternal smoking in ageing individuals. Here, we investigated the epidemiology and genomic architecture of maternal smoking in a middle-aged population and compare the results to effects observed in the developing foetus.

Methods: In the current project, we included 351,562 participants from the UK Biobank (UKB) and estimated exposure to maternal smoking status during pregnancy through self-reporting from the UKB participants about the mother's smoking status around their birth.

View Article and Find Full Text PDF

Background: Ventilator-associated pneumonia (VAP) is a frequent and severe complication among newborns in neonatal intensive care units (NICUs). It is associated with elevated morbidity and mortality rates, more extended hospital stays and increased health care costs. Implementing preventive care bundles and structured sets of evidence-based practices reduces VAP incidence.

View Article and Find Full Text PDF

Background: Pediatric acute respiratory distress syndrome (PARDS) has a mortality rate of up to 75%, which can be up to 90% in high-risk patients. Even with the use of advanced ventilation strategies, mortality remains unacceptably high at 40%. Airway pressure release ventilation (APRV) mode is a new strategy in PARDS.

View Article and Find Full Text PDF

Background: Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed chronic disease associated with progressive heart failure that results in impaired quality of life, repeated hospitalizations, and premature death. Acoramidis is a selective, oral transthyretin stabilizer recently approved by the U.S.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!